OHSU leadership on stage at AACR
Dozens of OHSU Knight Cancer Institute researchers commanded the spotlight at the American Association for Cancer Research Annual Meeting in Orlando, Florida. Lisa Coussens, Ph.D., who concluded...
Category: survivorship
How to help cancer patients with bone metastases get the benefits of exercise
An international panel including OHSU's Kerri Winters-Stone, Ph.D., has published best practice recommendations on exercise for people with cancer that has spread to their bones. "This consensus...
A new prescription for cancer: Exercise
Updated guidance details how physical activity, tailored to the individual, can reduce side effects and improve quality of life. “Take it easy” and “don’t overexert yourself” were common...
Should health plans cover fertility preservation for cancer patients?
Young adults undergoing toxic therapies for cancer have highly effective options to preserve fertility. But the great cost – easily $15,000 or more for a woman – puts the option out of the reach...
Exercise study aims to ameliorate the adverse effects of prostate cancer therapy
A clinical trial getting underway at OHSU will compare two types of exercise – tai chi versus strength training – as a means to prevent falls and injuries in men who've received androgen...
Exercise as medicine for cancer: Q&A with Kerri Winters-Stone
Cancer patients don’t need to avoid physical exertion, including exercise – contrary to once widely held belief. Exercise is not only safe during and after cancer treatment, studies have found...
Check out the Knight Cancer pilot project award winners
Preventing skin cancer with a DNA-repair enzyme. Understanding how microRNAs modify cancer immunity. Using zebrafish embryos to rapidly assess toxicity of anticancer drug combinations. These are...
How strength training may improve cancer survival
Cancer survivors who engage in strength training or other vigorous physical activity tend to live longer and have a lower risk of recurrence than those who don’t work out. A new study helps explain...
Unmasking the cost of cancer drug development
Cancer drug R&D spending may be a fraction of the estimate cited by the biopharmaceutical industry. The average price of anticancer drugs has been rising by about 10 percent annually in...
Surviving sarcoma: a free educational conference for patients, families
Sarcoma patients and their families are invited to participate in an interactive panel discussion and have their questions answered by OHSU physicians and surgeons who focus on the cancer, which...
Nerve damage from chemotherapy may persist for years, worsening risk of falls
In a study that kept in touch with more than 500 women cancer survivors for an average of six years, nearly half continued to experience chemotherapy-induced peripheral neuropathy and a heightened...